Chronic Obstructive Pulmonary Disease, Heart Failure
Conditions
Brief summary
The goal of this study is to evaluate the overall impact of Telehomecare on COPD and HF patients and system level outcomes using a comparison group of patients that did not participate in the program (for up to 18 months). This evaluation study will explore costs, participants' experiences, perceptions, and patterns of use related to Telehomecare. The study will include eight Local Health Integration Networks (LHINs) across Ontario, Canada.
Detailed description
The key question to answer is how different models of Telehomecare enabled self-management impacts patient outcomes, experiences and system costs across Ontario. The evaluation study will also attempt to answer questions on who is benefitting the most from the program and the quantifiable benefits a patient would experience from participating. The intervention evaluation study will use a mixed-methods design comprising of four components (sub-studies), using both qualitative and quantitative research methods: (1) Comparative Effectiveness Study that evaluates patient-level clinical outcomes (e.g. hospitalization, ED visits) using administrative data in comparison with usual care; (2) Economic Evaluation Study that will evaluate costs associated with the program and patient level outcomes as well as cost-effectiveness of the program in comparison with 'usual care'; (3) Evaluation study of Telehomecare use that will evaluate the patterns of program use and perceived quality of life, disease management, satisfaction and caregiver strain; and (4) Adoption study that will use ethnographic fieldwork, semi-structured interviews (during and after program participation) and review of documentary sources to gain understanding of program adoption.
Interventions
None listed
Sponsors
University Health Network, Toronto
University of Toronto
Study design
Observational model
OTHER
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Patient: * The patient has a documented diagnosis of HF or COPD (with or without co-morbid conditions); * The patient has been classified as a 'heavy user' of the health care system, characterized by any of the following: * A minimum of one hospitalization for a respiratory or cardiac complaint in the past six months; * A minimum of two emergency department/urgent care center visits for a respiratory or cardiac complaint in the past six months; * Currently receiving nursing services via CCAC; * Frequent visits to primary care provider in the past year; * Patient/informal caregiver (if applicable) is an adult (over 18 years), able and willing to provide informed consent; * Patient/informal caregiver (if applicable) is fluent in English; * Patient/informal caregiver is able and willing to operate the Telehomecare equipment; and * Patient lives in a residential (private home or retirement home) setting with an active landline. In addition to the program eligibility criteria, the following criteria for the intervention evaluation study apply to recruitment of patients: * Patient must have a documented consent for participating in Telehomecare * Patients enrolled in the Telehomecare program must have agreed to share their contact and health information for evaluative purposes * Patients must provide informed consent before participating in observations, interviews, and surveys as part of the program evaluation study Healthcare Provider A healthcare provider that has: * Referred a patient that has been previously enrolled in the Telehomecare program, and/or; * Provided primary care to a patient enrolled in the evaluation study * Previously or currently participated in delivering Telehomecare as a provider or care administrator; o For observations, interviews, and surveys: nurses/physicians must have at least 2 months experience in providing care using Telehomecare Technicians, Administrators, and/or Decision Makers The following are eligible for inclusion in the study: * Technicians involved in the set-up of Telehomecare equipment in the patient home. * Administrators and/or decision makers of the Telehomecare program as a larger network of care such as Healthcare Program Managers, key members of the LHINs, OTN etc.
Exclusion criteria
Patient * Less than 18 years of age; * Individuals without an established diagnosis of COPD or HF * Unable or unwilling to provide verbal informed consent * Demonstrated non-adherence to the THC program: o The Telehomecare Nurse works with each patient on a case-by-case review to assess willingness to partner in their own care, and if the number of missed consultation appointments and reasons for demonstrate overall non-adherence with the program; * Inability or unwillingness to use Telehomecare equipment, and/or; * Do not have a regular caregiver to assist in the use of the equipment (if assistance is required) Healthcare Provider * Is not a practicing healthcare provider in any of the said LHINs Technicians, Administrators and/or Decision Makers * Unable or unwilling to provide verbal informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Disease specific hospitalization and ED visits | 18 months | Comparison of disease specific hospitalization and ED visits between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of all-cause hospitalization/ED visits | 18 months | Comparison of the number of all-cause hospitalization/ED visits between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) |
| Number of visits to primary care physicians | 18 months | Comparison of the number of visits to primary care physicians between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) |
| Number of visits to specialists | 18 months | Comparison of the number of visits to specialists between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) |
| Number of visits to in-home health professionals | 18 months | Comparison of the number of visits to in-home health professionals between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) |
| Number of admissions to long-term care facilities | 18 months | Comparison of the number of admissions to long-term care facilities between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) |
| Length of stay in hospital | 18 months | Comparison of length-of-stay in hospital between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) |
| Medication use | 18 months | Comparison of medication use between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) |
Other
| Measure | Time frame | Description |
|---|---|---|
| Patient quality of life, disease self-management skills and satisfaction with Telehomecare | 12 months | Patterns of use of the program; patient quality of life, disease self-management skills and satisfaction with Telehomecare; Informal caregivers strain |
| Informal caregivers strain | 12 months | Patterns of use of the program; patient quality of life, disease self-management skills and satisfaction with Telehomecare; Informal caregivers strain |
| Costs associated with Telehomecare equipment and services | 18 months | Costs associated with Telehomecare equipment and services; comparison of health services costs for Telehomecare and 'usual care'; incremental cost-effectiveness ratio (ICER) of Telehomecare compared with 'usual care' |
| Comparison of health services costs for Telehomecare and 'usual care' | 18 months | Costs associated with Telehomecare equipment and services; comparison of health services costs for Telehomecare and 'usual care'; incremental cost-effectiveness ratio (ICER) of Telehomecare compared with 'usual care' |
| Incremental cost-effectiveness ratio (ICER) of Telehomecare compared with 'usual care' | 18 months | Costs associated with Telehomecare equipment and services; comparison of health services costs for Telehomecare and 'usual care'; incremental cost-effectiveness ratio (ICER) of Telehomecare compared with 'usual care' |
| Patterns of use of the program | 12 months | Patterns of use of the program; patient quality of life, disease self-management skills and satisfaction with Telehomecare; Informal caregivers strain |
| Perceptions and experiences of patients | 12 months | Perceptions and experiences of patients, informal caregivers, providers, administrators/decision-makers; overall adoption, integration and sustainability of the program |
| Overall adoption, integration and sustainability of the program | 12 months | Perceptions and experiences of patients, informal caregivers, providers, administrators/decision-makers; overall adoption, integration and sustainability of the program |
Countries
Canada
Contacts
Primary ContactValeria Rac, MD, PhD
Backup ContactNida Shahid
Outcome results
None listed